Ménière's disease

Ménière's disease
Name	Ménière's disease
Field	Otology, Neurology
Symptoms	Vertigo, tinnitus, hearing loss, aural fullness
Onset	Typically 40–60 years
Duration	Episodic
Causes	Unknown; associated with endolymphatic hydrops
Risks	Viral infection, autoimmune disease, head trauma, Allergy
Diagnosis	Clinical; audiometry, vestibular testing, MRI
Treatment	Dietary modification, pharmacotherapy, vestibular rehabilitation, surgery
Frequency	190 per 100,000 (estimated)

Ménière's disease is an inner ear disorder characterized by recurrent episodes of vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. First described in the 19th century, it has been studied across clinical otology, neurotology, and Neuroscience centers, with ongoing research in epidemiology, genetics, and therapeutics. Management spans lifestyle measures, medical interventions, and surgical options provided by specialists in tertiary referral centers.

Signs and symptoms

Patients typically present with spontaneous, rotational vertigo lasting minutes to hours, accompanied by unilateral tinnitus and low-frequency sensorineural hearing loss. Attacks often include a sensation of aural fullness and may be severe enough to cause nausea, vomiting, and postural imbalance requiring evaluation in emergency departments and clinics affiliated with institutions such as Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Massachusetts General Hospital. Between episodes, individuals may report persistent oscillopsia, progressive hearing impairment, and anxiety or depressive symptoms managed by teams at centers like Royal College of Surgeons clinics and university hospitals in Cambridge and Oxford.

Causes and risk factors

The precise etiology remains idiopathic, though associations have been reported with viral labyrinthitis (e.g., Herpesviridae), autoimmune inner ear disease identified in clinics linked to Cochrane reviews, and genetic predispositions studied in cohorts from Harvard Medical School, Stanford School of Medicine, University of California, San Francisco (UCSF). Risk factors include prior head trauma treated at trauma centers such as Addenbrooke's Hospital, chronic allergic rhinitis managed in ENT practices, and cardiovascular comorbidities assessed in studies at Imperial College London and Karolinska Institutet. Environmental and occupational exposures investigated by agencies like World Health Organization and Centers for Disease Control and Prevention are also considered in epidemiologic research.

Pathophysiology

Pathologic studies demonstrate endolymphatic hydrops—distention of the membranous labyrinth—linked to disturbances in endolymph homeostasis originally described by clinicians in 19th-century Parisian hospitals and later elaborated by researchers at Johns Hopkins University and UCL. Proposed mechanisms include impaired endolymph resorption via the endolymphatic sac, autoimmune-mediated inner ear inflammation documented in immunology labs at Karolinska Institutet and University of Pennsylvania, and ion transport dysregulation involving epithelial cells studied at Max Planck Institute and Cold Spring Harbor Laboratory. Vestibular nerve dysfunction and hair cell degeneration observed in temporal bone studies from Mayo Clinic and National Institutes of Health collections correlate with progressive audiovestibular decline.

Diagnosis

Diagnosis is clinical, based on paradigms endorsed by specialty societies such as the American Academy of Otolaryngology–Head and Neck Surgery and consensus panels convened at institutions like European Society for Paediatric Otorhinolaryngology meetings. Audiometry, including pure-tone and speech discrimination tests performed in audiology departments at Sheffield Teaching Hospitals and Royal National Throat, Nose and Ear Hospital, documents fluctuating low-frequency sensorineural loss. Vestibular testing—video head impulse test (vHIT), caloric testing, and vestibular-evoked myogenic potentials—are available at neurotology centers like Massachusetts Eye and Ear Infirmary. MRI of the internal auditory canals and brain, often ordered through radiology services at Guy's and St Thomas' NHS Foundation Trust and Karolinska University Hospital, is used to exclude vestibular schwannoma and other structural lesions.

Management and treatment

Initial management emphasizes vestibular suppression during acute attacks using vestibular sedatives and antiemetics commonly prescribed in emergency departments at St Thomas' Hospital and outpatient clinics affiliated with University College London Hospitals. Long-term strategies include dietary sodium restriction and diuretics as recommended in guidelines from the British Association of Otorhinolaryngologists, plus vestibular rehabilitation programs offered by physiotherapy departments at King's College Hospital and Toronto General Hospital. Intratympanic therapies—steroid injections and gentamicin ablation—are performed in tertiary centers such as Massachusetts Eye and Ear and Head and Neck Institute; surgical options (endolymphatic sac decompression, vestibular nerve section, labyrinthectomy) are reserved for refractory cases at high-volume centers including Mayo Clinic and Cleveland Clinic. Multidisciplinary care often involves audiologists from institutions like Royal Victorian Eye and Ear Hospital and psychologists from academic centers such as Yale School of Medicine.

Prognosis and complications

The clinical course is variable: some patients experience remission while others develop progressive bilateral sensorineural hearing loss and chronic imbalance, outcomes tracked in longitudinal cohorts at Johns Hopkins University, Karolinska Institutet, and University of Toronto. Complications include persistent disabling vertigo, permanent hearing impairment necessitating hearing aids or cochlear implantation performed at specialized centers like House Ear Institute and Johns Hopkins Cochlear Implant Center, and psychosocial sequelae managed by mental health services at academic hospitals such as Mayo Clinic and Mount Sinai Hospital. Prognostic factors under investigation by research groups at Imperial College London and Stanford University include baseline hearing levels, frequency of vertigo attacks, and bilateral involvement.

Category:Otology